BioCentury
ARTICLE | Company News

Curetis, Heraeus Medical deal

October 1, 2012 7:00 AM UTC

Curetis and Heraeus partnered to jointly develop a Unyvero cartridge to detect pathogens and antibiotic resistances in implant and tissue infections. The companies will co-fund development and said orthopedics would be a key application area. There are no licenses involved and the cartridge and application will be sold by Curetis as an in vitro diagnostic. Heraeus' customers will be given access to the product, while Curetis will pay a sales commission for any customer referrals by Heraeus to Curetis. The partners declined to provide financial details. ...